Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Leukemia | D007938 | — | C95 | 1 | 3 | 1 | — | — | 4 |
Sarcoma | D012509 | — | — | — | — | 1 | — | — | 1 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | — | — | 1 | — | — | 1 |
Myeloid leukemia | D007951 | — | C92 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Melanoma | D008545 | — | — | 2 | 2 | — | — | — | 2 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 1 | — | — | — | 2 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 1 | 2 | — | — | — | 2 |
Lymphoid leukemia | D007945 | — | C91 | 1 | 2 | — | — | — | 2 |
Myeloid leukemia acute | D015470 | — | C92.0 | — | 1 | — | — | — | 1 |
Lymphoma | D008223 | — | C85.9 | — | 1 | — | — | — | 1 |
Mantle-cell lymphoma | D020522 | — | C83.1 | — | 1 | — | — | — | 1 |
Carcinoma | D002277 | — | C80.0 | 1 | 1 | — | — | — | 1 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | 1 | — | — | — | 1 |
Neoplasms | D009369 | — | C80 | 1 | 1 | — | — | — | 1 |
Drug common name | Cilmostim |
INN | cilmostim |
Description | Cilmostim is a protein pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Protein |
Drug class | colony-stimulating factors: macrophage colony-stimulating factors (M-CSF) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2108239 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | EWL6971ETP (ChemIDplus, GSRS) |